Page last updated: 2024-12-06

antipain

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

Antipain: An oligopeptide produced by various bacteria which acts as a protease inhibitor. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID124527305
MeSH IDM0001492

Synonyms (1)

Synonym
antipain

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Micronutrient selenium is well known for its antioxidant properties; however, selenium exhibits a bimodal nature in that both its beneficial and toxic properties lie within a limited and narrow dose range."( Anticlastogenic and antigenotoxic effects of selenomethionine on doxorubicin-induced damage in vitro in human lymphocytes.
Santos, RA; Takahashi, CS, 2008
)
0.35

Dosage Studied

ExcerptRelevanceReference
" Kinetic dose-response studies showed that the number of cells induced to release virus was dependent on TPA concentration and the time of assay following TPA exposure."( Induction of type-C retrovirus by the tumor promotor TPA.
Hellman, A; Hellman, KB, 1981
)
0.26
" The effect of a non-cytotoxic dosage of AP (10 microM) was studied by: a) pretreating cells with AP for 48 hours before the carcinogen exposure; b) adding AP simultaneously to the carcinogen treatment; c) chronic addition of AP at each medium change throughout the experimental duration."( Effects of the protease inhibitor antipain on cell malignant transformation.
Argnani, A; Bartoli, S; Colacci, A; Giungi, M; Grilli, S; Horn, W; Mascolo, MG; Silingardi, P; Vaccari, M,
)
0.13
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (166)

TimeframeStudies, This Drug (%)All Drugs %
pre-199092 (55.42)18.7374
1990's44 (26.51)18.2507
2000's15 (9.04)29.6817
2010's14 (8.43)24.3611
2020's1 (0.60)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews3 (1.74%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other169 (98.26%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
"Evaluation of the Project Improvement of Nurse-led Self-management Support for Patients With Cancer-related Pain: An Accompanying Cluster Randomized Study With a Stepped Wedge Design" [NCT02891785]153 participants (Actual)Interventional2017-01-05Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]